2023 - Research.com Immunology in Germany Leader Award
2005 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Neurosciences
Immunology, Multiple sclerosis, Antibody, Antigen and Molecular biology are his primary areas of study. His Immunology and Glatiramer acetate, Myelin oligodendrocyte glycoprotein, Interferon, T cell and Cytokine investigations all form part of his Immunology research activities. His Cytokine research is multidisciplinary, incorporating perspectives in Tumor necrosis factor alpha, Myositis, Autoimmune disease, Genetic enhancement and Immunopathology.
The study incorporates disciplines such as Immunophenotyping, Central nervous system and Immune system, Immunotherapy in addition to Multiple sclerosis. His study looks at the relationship between Antibody and topics such as Pathology, which overlap with Apoptosis. His biological study deals with issues like Cytotoxic T cell, which deal with fields such as Inflammation, Programmed cell death, Inclusion body myositis and Fas receptor.
Reinhard Hohlfeld mainly investigates Multiple sclerosis, Immunology, Internal medicine, Pathology and Antibody. Reinhard Hohlfeld has researched Multiple sclerosis in several fields, including Disease, Neuroscience and Intensive care medicine. His study in Antigen, Myasthenia gravis, T cell, Immune system and Autoantibody is carried out as part of his Immunology studies.
His research on T cell also deals with topics like
The scientist’s investigation covers issues in Multiple sclerosis, Immunology, Internal medicine, Pathology and In patient. He studies Myelin oligodendrocyte glycoprotein, a branch of Multiple sclerosis. His study in Autoantibody, Autoimmunity, Experimental autoimmune encephalomyelitis, Immune system and Antibody falls under the purview of Immunology.
His Autoimmunity research includes themes of Mutation, T cell and B cell. His biological study spans a wide range of topics, including Penetrance, Fingolimod, Oncology and Endocrinology. As part of the same scientific family, he usually focuses on Pathology, concentrating on T-cell receptor and intersecting with Brain lesions, Alpha chain, Single-cell analysis and Peptide sequence.
His primary scientific interests are in Multiple sclerosis, Immunology, Pathology, Receptor and Myelin oligodendrocyte glycoprotein. His study in Multiple sclerosis is interdisciplinary in nature, drawing from both Mutation, Interferon, Phenotype, CD8 and Disease. Immunology is represented through his Experimental autoimmune encephalomyelitis, Autoimmunity, Immunoglobulin M, Affinity maturation and Cytidine deaminase research.
He interconnects Complementarity determining region, Molecular biology, T-cell receptor, B-Cell Maturation Antigen and Bone marrow in the investigation of issues within Receptor. His work carried out in the field of Myelin oligodendrocyte glycoprotein brings together such families of science as Antibody, Neuromyelitis optica, Flow cytometry, Atrophy and Subclinical infection. His Internal medicine study combines topics from a wide range of disciplines, such as Extracellular, Endocrinology, Cellular differentiation and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos;Ernst Wilhelm Radue;Paul O'Connor;Chris Polman.
The New England Journal of Medicine (2010)
Polymyositis and Dermatomyositis
Marinos C Dalakas;Reinhard Hohlfeld.
Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
Holger Babbe;Axel Roers;Ari Waisman;Hans Lassmann.
Journal of Experimental Medicine (2000)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
Markus Krumbholz;Diethilde Theil;Tobias Derfuss;Andreas Rosenwald.
Journal of Experimental Medicine (2005)
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Kerstin Berer;Lisa Ann Gerdes;Egle Cekanaviciute;Xiaoming Jia.
Proceedings of the National Academy of Sciences of the United States of America (2017)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Andreas Junker;Markus Krumbholz;Sylvia Eisele;Hema Mohan.
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Markus Krumbholz;Diethilde Theil;Sabine Cepok;Bernhard Hemmer.
BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?
Christine Stadelmann;Martin Kerschensteiner;Thomas Misgeld;Wolfgang Brück.
Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.
Multiple sclerosis: Brain-infiltrating CD8(+) T cells persist as clonal expansions in the cerebrospinal fluid and blood
Christian Skulina;Stephan Schmidt;Klaus Dornmair;Holger Babbe.
Proceedings of the National Academy of Sciences of the United States of America (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: